新基因组学公司
| Security | NEO / NeoGenomics, Inc. |
| Insider | Christopher M Smith |
This page shows the track record and history of Smith Christopher M
insider trades in NeoGenomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Christopher M Smith in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Christopher M Smith in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-25 | 2025-02-23 | 4 | Smith Christopher M | NEO | Common Stock | D | -14,067 | 641,585 | ||||||
| 2025-02-25 | 2025-02-23 | 4 | Smith Christopher M | NEO | Common Stock | D | 57,413 | 655,652 | ||||||
| 2024-12-04 | 2024-05-11 | 4/A | Smith Christopher M | NEO | Common Stock | D | 14.8600 | -18,913 | -281 | 631,369 | ||||
| 2024-12-04 | 2024-05-11 | 4/A | Smith Christopher M | NEO | Common Stock | D | 48,063 | 650,282 | ||||||
| 2024-08-19 | 2024-08-15 | 4 | Smith Christopher M | NEO | Common Stock | D | -33,130 | 646,302 | ||||||
| 2024-05-14 | 2024-05-11 | 4 | Smith Christopher M | NEO | Common Stock | D | 48,063 | 679,432 | ||||||
| 2024-05-14 | 2024-05-11 | 4 | Smith Christopher M | NEO | Common Stock | D | 48,063 | 679,432 | ||||||
| 2024-05-14 | 2024-05-11 | 4 | Smith Christopher M | NEO | Common Stock | D | 14.8600 | -18,913 | -281 | 631,369 | ||||
| 2022-08-17 | 2022-08-15 | 4 | Smith Christopher M | NEO | Common Stock | D | 265,452 | 602,219 | ||||||
| 2022-08-17 | 2022-08-15 | 4 | Smith Christopher M | NEO | Common Stock | D | 336,767 | 336,767 |
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）
